Samuel Hellmän

16.9k total citations · 2 hit papers
238 papers, 10.8k citations indexed

About

Samuel Hellmän is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Samuel Hellmän has authored 238 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cancer Research, 68 papers in Oncology and 58 papers in Pathology and Forensic Medicine. Recurrent topics in Samuel Hellmän's work include Breast Cancer Treatment Studies (55 papers), Lymphoma Diagnosis and Treatment (35 papers) and Effects of Radiation Exposure (32 papers). Samuel Hellmän is often cited by papers focused on Breast Cancer Treatment Studies (55 papers), Lymphoma Diagnosis and Treatment (35 papers) and Effects of Radiation Exposure (32 papers). Samuel Hellmän collaborates with scholars based in United States, United Kingdom and Belgium. Samuel Hellmän's co-authors include Ralph R. Weichselbaum, Jay R. Harris, Martin B. Levene, Peter Mauch, Leslie E. Botnick, David W. Kinne, Stanley E. Order, Göran Svensson, Ruth Heimann and Susan Groshen and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Samuel Hellmän

232 papers receiving 10.0k citations

Hit Papers

Oligometastases revisited 1979 2026 1994 2010 2011 1979 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Hellmän United States 57 3.8k 3.8k 3.0k 2.8k 2.1k 238 10.8k
Marie Overgaard Denmark 55 4.3k 1.1× 7.3k 2.0× 2.6k 0.9× 3.3k 1.2× 4.0k 1.9× 139 12.5k
Carsten Rose Denmark 38 3.1k 0.8× 4.6k 1.2× 1.0k 0.3× 2.0k 0.7× 1.7k 0.8× 115 7.2k
Allen S. Lichter United States 56 3.7k 1.0× 3.8k 1.0× 4.0k 1.3× 2.1k 0.8× 2.0k 1.0× 159 11.2k
Michael Andersson Denmark 37 3.2k 0.8× 2.2k 0.6× 1.7k 0.6× 1.6k 0.6× 1.7k 0.8× 123 7.6k
Wim L.J. van Putten Netherlands 56 2.6k 0.7× 1.2k 0.3× 2.8k 0.9× 1.0k 0.4× 1.5k 0.7× 155 10.5k
Alan Horwich United Kingdom 45 2.6k 0.7× 1.5k 0.4× 5.6k 1.8× 1.8k 0.6× 2.4k 1.2× 140 10.4k
I. Craig Henderson United States 50 7.5k 2.0× 5.2k 1.4× 1.5k 0.5× 1.7k 0.6× 879 0.4× 153 11.8k
M Tubiana France 46 2.6k 0.7× 1.2k 0.3× 1.8k 0.6× 2.6k 0.9× 909 0.4× 272 7.4k
Bernard Asselain France 59 5.2k 1.4× 4.4k 1.2× 2.1k 0.7× 2.6k 0.9× 1.8k 0.9× 323 11.0k
Joachim Yahalom United States 65 4.9k 1.3× 1.4k 0.4× 2.7k 0.9× 8.6k 3.0× 1.1k 0.5× 272 14.5k

Countries citing papers authored by Samuel Hellmän

Since Specialization
Citations

This map shows the geographic impact of Samuel Hellmän's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Hellmän with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Hellmän more than expected).

Fields of papers citing papers by Samuel Hellmän

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Hellmän. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Hellmän. The network helps show where Samuel Hellmän may publish in the future.

Co-authorship network of co-authors of Samuel Hellmän

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Hellmän. A scholar is included among the top collaborators of Samuel Hellmän based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Hellmän. Samuel Hellmän is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katipally, Rohan, Sean P. Pitroda, Ralph R. Weichselbaum, & Samuel Hellmän. (2023). Oligometastases: Characterizing the Role of Epigenetic Regulation of Epithelial–Mesenchymal Transition. Clinical Cancer Research. 29(15). 2761–2766. 5 indexed citations
2.
Oshima, Go, Melinda E. Stack, Sean C. Wightman, et al.. (2016). Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones. Journal of Visualized Experiments. 3 indexed citations
3.
Prosnitz, Leonard R., Ira S. Goldenberg, Jay R. Harris, et al.. (2015). Radiotherapy for Carcinoma of the Breast Instead of Mastectomy An Update. Frontiers of radiation therapy and oncology. 17. 69–75.
4.
Lussier, Yves A., Nikolai N. Khodarev, Kelly Regan, et al.. (2013). Correction: Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs. PLoS ONE. 8(6).
5.
Weichselbaum, Ralph R., Joseph K. Salama, Neil Mehta, et al.. (2006). 2564. International Journal of Radiation Oncology*Biology*Physics. 66(3). S523–S523. 3 indexed citations
6.
Jani, Ashesh B., Johnny Kao, & Samuel Hellmän. (2003). Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma. Cancer. 98(11). 2351–2361. 14 indexed citations
7.
Park, James O., Carlos López, Vinay Gupta, et al.. (2002). Transcriptional control of viral gene therapy by cisplatin. Journal of Clinical Investigation. 110(3). 403–410. 36 indexed citations
8.
Park, James O., Carlos López‐Jaramillo, Vinay Gupta, et al.. (2002). Transcriptional control of viral gene therapy by cisplatin. Journal of Clinical Investigation. 110(3). 403–410. 1 indexed citations
9.
Heimann, Ruth & Samuel Hellmän. (1998). Aging, progression, and phenotype in breast cancer.. Journal of Clinical Oncology. 16(8). 2686–2692. 35 indexed citations
10.
Hellmän, Samuel. (1997). Darwin's clinical relevance. Cancer. 79(12). 2275–2281. 20 indexed citations
11.
Heimann, Ruth, et al.. (1997). 3 Angiogenesis and estrogen receptor (ER) in young women with breast cancer. International Journal of Radiation Oncology*Biology*Physics. 39(2). 136–136. 4 indexed citations
12.
Mauceri, Helena J., Nader Hanna, Jeffrey D. Wayne, et al.. (1996). Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.. PubMed. 56(19). 4311–4. 89 indexed citations
13.
Schull, William J., et al.. (1995). Effects of Atomic Radiation: A half–century of studies from Hiroshima and Nagasaki. Nature Medicine. 1(12). 1315–1315. 12 indexed citations
14.
15.
Shank, Brenda & Samuel Hellmän. (1987). Preservative surgery and radiation therapy in the treatment of early breast cancer. 1 indexed citations
16.
Harris, Jay R., Samuel Hellmän, & David W. Kinne. (1986). Limited Surgery and Radiotherapy For Early Breast Cancer. CA A Cancer Journal for Clinicians. 36(2). 120–125. 4 indexed citations
17.
Mauch, Peter, Thomas E. Goffman, David I. Rosenthal, et al.. (1985). Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone.. Journal of Clinical Oncology. 3(9). 1166–1173. 52 indexed citations
18.
Harris, Jeffrey R., James L. Connolly, Stuart J. Schnitt, Richard B. Cohen, & Samuel Hellmän. (1983). Clinical-pathologic study of early breast cancer treated by primary radiation therapy.. Journal of Clinical Oncology. 1(3). 184–189. 51 indexed citations
19.
Hellmän, Samuel, et al.. (1979). Nature of the hemopoietic stem cell compartment and its proliferative potential.. PubMed. 5(2). 195–210. 34 indexed citations
20.
Weichselbaum, Ralph R., Samuel Hellmän, Anthony J. Piro, John Nove, & John B. Little. (1978). Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(8). 2339–42. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026